BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10799722)

  • 1. ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
    Bernier J; Denekamp J; Rojas A; Minatel E; Horiot J; Hamers H; Antognoni P; Dahl O; Richaud P; van Glabbeke M; Piérart M
    Radiother Oncol; 2000 May; 55(2):111-9. PubMed ID: 10799722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
    Bernier J; Denekamp J; Rojas A; Trovò M; Horiot JC; Hamers H; Antognoni P; Dahl O; Richaud P; Kaanders J; van Glabbeke M; Piérart M
    Radiother Oncol; 1999 Aug; 52(2):149-56. PubMed ID: 10577700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ; Rojas AM; Phillips H; Saunders MI
    Cancer; 2005 Jun; 103(11):2287-97. PubMed ID: 15834926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
    Bussink J; Kaanders JH; Van der Kogel AJ
    Acta Oncol; 1999; 38(7):875-82. PubMed ID: 10606417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
    Kaanders JH; Pop LA; Marres HA; Liefers J; van den Hoogen FJ; van Daal WA; van der Kogel AJ
    Radiother Oncol; 1998 Aug; 48(2):115-22. PubMed ID: 9783882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARCON: experience in 215 patients with advanced head-and-neck cancer.
    Kaanders JH; Pop LA; Marres HA; Bruaset I; van den Hoogen FJ; Merkx MA; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):769-78. PubMed ID: 11849800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
    Bernier J; Stratford MR; Denekamp J; Dennis MF; Bieri S; Hagen F; Kocagöncü O; Bolla M; Rojas A
    Radiother Oncol; 1998 Aug; 48(2):123-33. PubMed ID: 9783883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.
    Saunders MI; Hoskin PJ; Pigott K; Powell ME; Goodchild K; Dische S; Denekamp J; Stratford MR; Dennis MF; Rojas AM
    Radiother Oncol; 1997 Nov; 45(2):159-66. PubMed ID: 9424007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
    Hoogsteen IJ; Pop LA; Marres HA; Merkx MA; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):83-9. PubMed ID: 16213107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
    Miralbell R; Mornex F; Greiner R; Bolla M; Storme G; Hulshof M; Bernier J; Denekamp J; Rojas AM; Pierart M; van Glabbeke M; Mirimanoff RO
    J Clin Oncol; 1999 Oct; 17(10):3143-9. PubMed ID: 10506611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON).
    Zackrisson B; Franzén L; Henriksson R; Littbrand B; Stratford M; Dennis M; Rojas AM; Denekamp J
    Acta Oncol; 1994; 33(4):377-81. PubMed ID: 8018369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.
    Janssens GO; Rademakers SE; Terhaard CH; Doornaert PA; Bijl HP; van den Ende P; Chin A; Marres HA; de Bree R; van der Kogel AJ; Hoogsteen IJ; Bussink J; Span PN; Kaanders JH
    J Clin Oncol; 2012 May; 30(15):1777-83. PubMed ID: 22508814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARCON: a novel biology-based approach in radiotherapy.
    Kaanders JH; Bussink J; van der Kogel AJ
    Lancet Oncol; 2002 Dec; 3(12):728-37. PubMed ID: 12473514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.
    Fatigante L; Ducci F; Cartei F; Colosimo S; Marini C; Prediletto R; Danesi R; Laddaga M; Del Tacca M; Caciagli P
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):499-504. PubMed ID: 9112444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
    Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
    Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancer.
    Janssens GO; Rademakers SE; Terhaard CH; Doornaert PA; Bijl HP; van den Ende P; Chin A; Takes RP; de Bree R; Hoogsteen IJ; Bussink J; Span PN; Kaanders JH
    Clin Cancer Res; 2014 Mar; 20(5):1345-54. PubMed ID: 24452791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.
    Kaanders JH; Pop LA; Marres HA; van der Maazen RW; van der Kogel AJ; van Daal WA
    Radiother Oncol; 1995 Dec; 37(3):190-8. PubMed ID: 8746587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute toxicity profile and compliance to accelerated radiotherapy plus carbogen and nicotinamide for clinical stage T2-4 laryngeal cancer: results of a phase III randomized trial.
    Janssens GO; Terhaard CH; Doornaert PA; Bijl HP; van den Ende P; Chin A; Pop LA; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):532-8. PubMed ID: 21300447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
    Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbogen breathing combined with radical radiotherapy in advanced head and neck cancer patients with severe co-morbidities.
    Vees H; Allal AS
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):493-6. PubMed ID: 16909974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.